Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Retatrutide
History
Retatrutide is an investigational synthetic peptide designed as a triple receptor agonist, activating the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. It was developed to investigate whether targeting all three pathways simultaneously could produce greater effects on weight loss and metabolic health than earlier incretin-based therapies.
Research Use
Researchers study Retatrutide for its potential effects on:
Weight management
Blood glucose regulation
Appetite control
Energy expenditure
Body composition
Metabolic health
Clinical Highlights
Studied for producing substantial weight loss in clinical trials through combined appetite suppression and increased energy expenditure
Investigated for improving blood sugar control and insulin sensitivity
May reduce visceral fat while helping preserve lean body mass in research settings
Explored for potential benefits in obesity, type 2 diabetes, and metabolic dysfunction–associated liver disease
Research is ongoing to evaluate its long-term safety, cardiovascular effects, and broader therapeutic potential
Retatrutide
History
Retatrutide is an investigational synthetic peptide designed as a triple receptor agonist, activating the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. It was developed to investigate whether targeting all three pathways simultaneously could produce greater effects on weight loss and metabolic health than earlier incretin-based therapies.
Research Use
Researchers study Retatrutide for its potential effects on:
Weight management
Blood glucose regulation
Appetite control
Energy expenditure
Body composition
Metabolic health
Clinical Highlights
Studied for producing substantial weight loss in clinical trials through combined appetite suppression and increased energy expenditure
Investigated for improving blood sugar control and insulin sensitivity
May reduce visceral fat while helping preserve lean body mass in research settings
Explored for potential benefits in obesity, type 2 diabetes, and metabolic dysfunction–associated liver disease
Research is ongoing to evaluate its long-term safety, cardiovascular effects, and broader therapeutic potential